White Paper: Why Annex 1 Is Important to You

This white paper details the key reasons for the revision to EudraLex Volume 4, Annex 1: Manufacture of Sterile Medicinal Products. It outlines what you should be asking yourself regardless of the dosage form you are responsible for. It also includes a simple tool to assess the impact on your organization when there is a regulatory change.

Listen to the audio version

How NSF Can Help You

Get in touch to find out how we can help you and your business thrive.

What’s New with NSF